drugset / Trial / NCT04602689

Fibrin Glue After ESD for High Risk Patients of Bleeding

NCT04602689 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

It is a prospective randomized controlled study to look for effectiveness of fibrin glue to prevent bleeding in high-risk patients after endoscopic submucosal dissection in gastric neoplasm.

Timeline

Start
2020-10-30
Primary completion
2022-07-14
Completion
2022-07-14

Outcome

Missed primary endpoint

paper This trial failed to show a preventive effect of fibrin glue on overall post-ESD bleeding in high-risk patients. PMID 36594814 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprotinin Unknown — Topical
Subject Calcium chloride hydrate Unknown — Topical
Subject Human fibrinogen concentrate Protein / enzyme biologic — Topical
Subject thrombin Protein / enzyme biologic — Topical